To view this email as a web page, click here.
October 16, 2019
 
Focus on Therapeutic Cataract & Refractive Surgery
 
Newer options optimize pharmaceutical management for lens surgery patients
Surgeons today can choose from a number of newer modalities that address the drawbacks associated with previous options, said William D. Trattler, MD.
Learn more
 
ADVERTISEMENT
 
Quieting the neuropathic components of ocular pain
image description here Patients with chronic ocular pain may benefit from the use of nerve blocks that generally are used to treat peripheral neuropathic pain elsewhere in the body.

Learn more
 
Large population-based study questions value of routine NSAID use after cataract surgery
image description here Results of randomized controlled trials indicate that the occurrence of CME is reduced in eyes treated with an NSAID, either in combination with a steroid or alone. However, it is sometimes difficult to relate study results to what is perceived as clinical reality, says Jan Gärdin, MD.

Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.